The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation. This evidence concerns the gene HERC1 and chronic myelogenous leukemia, BCR-ABL1 positive.